PRISM Vision Acquisition Will Expand Specialty Services In Retina And Ophthalmology

AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Published
18 Jul 24
Updated
31 Jul 25
AnalystConsensusTarget's Fair Value
US$779.79
8.8% undervalued intrinsic discount
31 Jul
US$710.94
Loading
1Y
16.0%
7D
0.7%

Author's Valuation

US$779.8

8.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Increased 5.58%

Shared on30 Apr 25
Fair value Increased 0.92%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Increased 1.10%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Increased 1.85%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 1.54%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 4.76%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 0.78%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Decreased 13%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.